NCT06872749

Brief Summary

This randomized, single-blind, placebo-controlled clinical trial aims to clinically evaluate the effect of an experimental gel containing copaiba oleo-resin in the control of dentin hypersensitivity (DH) in non-carious cervical lesions (NCCL). Seventy-five hypersensitive teeth will be selected into three groups (N=25) and approved in three treatment sessions. The groups will be: GROUP P= water-soluble placebo gel without active ingredient; GROUP KF2: Potassium nitrate 5% + Sodium fluoride 2%; GROUP GC: Gel containing copaiba oleo-resin. A visual analogue scale (VAS) will be used to compare the DH after tactile stimulation with an exploratory probe and evaporative stimulation with air jets. The DH assessments will be performed at four times: baseline, after 1 week, 15 days and 30 days after the beginning of treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 16, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 12, 2025

Completed
Last Updated

May 20, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

January 16, 2025

Last Update Submit

May 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • sensitivity assessment

    Evaluation of hypersensitivity in teeth with non-carious cervical lesions. Patients will be instructed to complete a form to record tooth sensitivity before the application of the gels. An evaluation will be performed at baseline, 7 days, 15 days and 30 days, based on their individual perception of pain. The evaluation form will consist of a visual analogue scale (VAS). This scale consists of a 10 cm horizontal line with points of 0 and 10 at its ends, where 0 means no sensitivity and 10 means severe tooth sensitivity. The patient will be instructed to draw a vertical line along the horizontal line of the scale, recording the intensity of tooth sensitivity. So that the distance in millimeters from the zero end can later be measured with the aid of a millimeter ruler, thus obtaining the intensity level of the patient's back.

    30 days

Study Arms (3)

Placebo gel

PLACEBO COMPARATOR

the group will receive the application of gel without active ingredient

Other: Placebo gel

KF2 (Potassium nitrate gel)

ACTIVE COMPARATOR

the group will receive the application of gel containing potassium nitrate

Other: KF2 (Potassium nitrate gel)

Copaiba gel

EXPERIMENTAL

the group will receive the application of gel containing copaiba

Other: experimental Copaiba gel

Interventions

will receive the application of a placebo gel (without active ingredient), under the same conditions described for the experimental gel.

Placebo gel

will receive application of potassium nitrate gel on hypersensitive dental surfaces, in an active way, for 10 minutes.

KF2 (Potassium nitrate gel)

will receive the application of the experimental desensitizing gel on the vestibular surfaces of the hypersensitive teeth in an active manner, for 10 minutes.

Copaiba gel

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • hypersensitive areas on the vestibular surface of the teeth with exposed cervical dentin up to 1 mm deep and/or class I gingival recession according to the Miller classification;
  • individuals who have at least two hypersensitive teeth
  • periodontal health,
  • good general physical health;
  • willingness to participate in the research by providing written informed consent;
  • no eating disorders or very acidic diets

You may not qualify if:

  • presence of restorations;
  • presence of dental caries and periodontal pockets;
  • ongoing treatment with antibiotics and/or anti-inflammatory and/or analgesic drugs;
  • professional desensitizing treatment received three months prior to the study;
  • pregnancy or lactation; systemic diseases;
  • pulpitis;
  • use of orthodontic appliances or dental prostheses that may interfere with the assessment of hypersensitivity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Federal Do Para

Belém, Pará, Brazil

Location

MeSH Terms

Conditions

PainDentin Sensitivity

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsTooth DiseasesStomatognathic Diseases

Study Officials

  • Cecy M Silva, Doctor

    universidade federal do pará

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of the Graduate Program in Dentistry at the Federal University of Pará

Study Record Dates

First Submitted

January 16, 2025

First Posted

March 12, 2025

Study Start

September 20, 2024

Primary Completion

March 10, 2025

Study Completion

March 10, 2025

Last Updated

May 20, 2025

Record last verified: 2025-03

Locations